Quick Overview.
Cerebrolysin is a highly unique, multi-modal neurotrophic drug. Unlike synthetic peptides (like Semax or Dihexa), Cerebrolysin is a biologically derived mixture of purified porcine (pig) brain proteins and peptides. It has been used clinically in Europe and Asia for decades as a primary treatment for acute ischemic stroke, traumatic brain injury (TBI), and Alzheimer's disease.[1]
In the biohacking and longevity communities, Cerebrolysin is considered the "gold standard" for profound neurological repair. Because it contains a natural cocktail of neurotrophic factors (including BDNF, GDNF, NGF, and CNTF), it mimics the brain's own natural healing processes. However, it must be administered via intramuscular (IM) or intravenous (IV) injection, and the volume of liquid required is significantly larger than standard peptide injections.[2]
- Primary Use Case: Recovery from traumatic brain injury (concussions), stroke rehabilitation, severe cognitive decline, and neuro-regeneration after substance abuse.
- Mechanism: Delivers a broad spectrum of low-molecular-weight neurotrophic factors that cross the blood-brain barrier to stimulate neurogenesis, synaptogenesis, and neuroprotection.[3]
- Who it is for: Individuals recovering from brain trauma, stroke, or severe cognitive burnout, and advanced biohackers seeking profound neuroplasticity.
- Who it is NOT for: Individuals who are squeamish about needles (it requires large IM injections) or those with severe kidney impairment.
Turn this protocol into your actual schedule.
Log every dose, every side-effect, and every PR on one timeline.
The Protocol & Usage Guide.
confidence_tier: well-established
Cerebrolysin is supplied in glass ampoules (typically 2mL, 5mL, or 10mL). Because it is a biological product, once an ampoule is cracked open, the entire contents must be used immediately; it cannot be saved for later due to the risk of bacterial contamination.[4]
Standard Dosing Schedule
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| Mild Cognitive Enhancement | 2 mL to 5 mL | 5 days on, 2 days off | Intramuscular (IM) |
| TBI / Concussion Recovery | 5 mL to 10 mL | 5 days on, 2 days off | Intramuscular (IM) |
| Acute Stroke (Clinical) | 20 mL to 50 mL | Daily for 10-21 days | Intravenous (IV) Infusion |
Cycle Length & Discontinuation Protocol
- Cycle Length: A standard biohacking or TBI recovery cycle is 4 weeks (e.g., 5 days per week for 4 weeks).
- Injection Logistics: A 5mL or 10mL dose is a massive volume of liquid for an intramuscular injection. It must be injected into a large muscle group (like the glutes or ventrogluteal site) using a larger needle (e.g., 1-inch to 1.5-inch, 23G to 25G). Doses over 5mL are often split into two separate syringes and injected into two different sites.
- Discontinuation: No tapering is required. The neuroplastic changes are structural and long-lasting.
Nutritional Support & Recommended Supplements.
confidence_tier: community
| Supplement | Rationale | Recommended Dose |
|---|---|---|
| Omega-3 Fish Oil (High DHA) | Provides the structural lipids required for the massive amount of synaptogenesis stimulated by Cerebrolysin. | 3-4g daily. |
| B-Complex Vitamins | Supports overall cellular metabolism and methylation during the brain-rebuilding phase. | Standard label dose. |
| L-Theanine | Cerebrolysin can sometimes cause mild overstimulation or vivid dreams; L-Theanine helps smooth out the nervous system. | 200mg as needed. |
Safety, Interactions & Side Effect Management.
confidence_tier: well-established
Side Effect Profile
| Side Effect | Severity | Frequency | Management |
|---|---|---|---|
| Injection Site Pain | Moderate | Common | Injecting 5mL of fluid into a muscle causes tissue distension. Inject slowly and massage the area afterward. |
| Brain Fog / Fatigue | Mild | Occasional | The brain requires massive amounts of energy to build new synapses. "Healing fatigue" is common during the first week. |
| Vivid Dreams | Mild | Common | Increased neuroplasticity often leads to intense, highly detailed dreams. |
| Fever / Chills | Mild | Rare | Because it is a biological product, a mild immune response can occasionally occur. |
Contraindications
- Absolute: Individuals with severe renal (kidney) impairment. The breakdown products of the peptides are excreted via the kidneys.
- Absolute: Individuals with a known allergy to porcine (pig) proteins.
- Relative: Individuals with a history of severe epilepsy, as massive neurogenesis can theoretically alter seizure thresholds (though clinical data on this is mixed).
Common Stacks & Combinations.
confidence_tier: community
| Stack | Goal | Rationale |
|---|---|---|
| Cerebrolysin + Cortexin | The Russian TBI Stack | Cortexin is a similar porcine-derived neurotrophic drug, but it is richer in neuropeptides specific to the cerebral cortex. Stacking them provides a broader spectrum of repair. |
| Cerebrolysin + Hyperbaric Oxygen (HBOT) | Extreme Stroke Recovery | HBOT forces oxygen deep into ischemic brain tissue, while Cerebrolysin provides the growth factors to rebuild that tissue. |
Body Composition & Training Guide.
confidence_tier: well-established
- Not a Muscle Builder: Cerebrolysin has no direct effect on muscle hypertrophy.
- CNS Recovery: Elite strength athletes (like powerlifters) occasionally use Cerebrolysin to recover from severe Central Nervous System (CNS) burnout caused by months of heavy 1-rep max training.
- Motor Skill Rehabilitation: In stroke patients, Cerebrolysin is almost always paired with intense physical therapy. The drug makes the brain "plastic" enough to relearn how to walk, speak, and move.
Storage, Handling & Accessibility.
confidence_tier: well-established
- Storage: Store glass ampoules at room temperature (do not freeze). Keep away from direct sunlight.
- Handling: Once an ampoule is broken, the liquid must be drawn into a syringe and injected immediately. It does not contain preservatives.
- WADA Status: Banned in-competition under section S2 (Peptide Hormones, Growth Factors).
- Cost & Accessibility: Widely available from European and Russian pharmacies online. It is relatively affordable compared to synthetic peptides, but shipping heavy glass ampoules can be expensive.
Bloodwork Monitoring Guide.
confidence_tier: well-established
| Biomarker | When to Test | Why it Matters |
|---|---|---|
| BUN / Creatinine (Kidneys) | Baseline | Cerebrolysin is contraindicated in patients with severe renal impairment. Ensure kidney function is normal before starting a heavy cycle. |
| C-Reactive Protein (CRP) | Baseline, Mid-Cycle | To monitor for any systemic inflammatory response to the porcine proteins. |
Comparison to Similar Compounds.
confidence_tier: well-established
| Feature | Cerebrolysin | Semax | Dihexa |
|---|---|---|---|
| Source | Biological (Porcine) | Synthetic | Synthetic |
| Primary Goal | TBI / Stroke Recovery | Focus / ADHD | Extreme Synaptogenesis |
| Delivery | IM / IV Injection | Nasal Spray | Oral / Transdermal |
| Volume Required | Massive (2mL - 10mL) | Tiny (Micrograms) | Tiny (Milligrams) |
| Clinical Data | Extensive (Decades) | Extensive (Russia) | None (Preclinical only) |
Deep Dive (For Advanced Researchers).
confidence_tier: well-established
The "Pleiotropic" Mechanism of Action
Unlike synthetic drugs that target a single receptor, Cerebrolysin is a "pleiotropic" agent—it acts on multiple targets simultaneously. It contains low-molecular-weight peptides (<10 kDa) that mimic the action of endogenous neurotrophic factors.
- Neuroprotection: In the acute phase of a stroke or TBI, Cerebrolysin reduces excitotoxicity by modulating NMDA receptors, decreases free radical production, and inhibits apoptosis (programmed cell death) by downregulating pro-apoptotic proteins like Bax and upregulating anti-apoptotic proteins like Bcl-2.
- Neuroregeneration: In the subacute and chronic phases, it stimulates the proliferation of neural stem cells in the dentate gyrus and subventricular zone, and promotes the sprouting of new dendrites and axons.[5][6]
Clinical Efficacy in Stroke (The CARS Trial)
The Cerebrolysin and Recovery After Stroke (CARS) trial was a landmark, randomized, double-blind, placebo-controlled study.
- Patients who received Cerebrolysin (30mL/day IV for 21 days) beginning within 72 hours of an acute ischemic stroke showed significantly superior motor recovery in their upper extremities compared to the placebo group at 90 days.
- Meta-analyses of multiple stroke trials confirm that Cerebrolysin not only improves motor function but also significantly enhances overall functional independence and activities of daily living (ADL) scores.[7][8]
Efficacy in Traumatic Brain Injury (The CAPTAIN Trial)
The CAPTAIN (Cerebrolysin After moderate to severe Traumatic brain injury) retrospective cohort study demonstrated that Cerebrolysin administration significantly improved the Glasgow Outcome Scale (GOS) and reduced mortality in patients with severe TBI. It is particularly effective at reducing the diffuse axonal injury (shearing of the brain's white matter) that occurs during concussive impacts.[9]
Frequently Asked Questions (FAQ).
confidence_tier: community
Q: Can I drink Cerebrolysin instead of injecting it? A: No. The peptides will be completely destroyed by stomach acid and digestive enzymes. It must be injected IM or IV.
Q: Is there a risk of prion disease (like Mad Cow) from pig brains? A: The risk is virtually zero. Cerebrolysin is manufactured under strict European pharmaceutical standards. The proteins are enzymatically cleaved and ultra-filtered to ensure no large proteins or prions can survive the process. It has been used safely in millions of patients for over 40 years.
Q: Why do I feel so tired after my injection? A: Neurogenesis is a highly metabolically demanding process. Your brain is literally building new physical structures. This "healing fatigue" is a sign that the drug is working. Rest and eat well.
International Regulatory Status.
confidence_tier: well-established
| Agency | Status | Notes |
|---|---|---|
| US FDA | Unapproved | Not approved for medical use in the US. |
| WADA | Banned | Prohibited in-competition under S2. |
| Russia / CIS / Asia | Approved | Standard-of-care medical drug for stroke, TBI, and dementia. |
| EU EMA | Approved | Approved in several European countries (e.g., Austria, Germany). |
Decision Tree.
confidence_tier: community
[Goal: Recovery from TBI, Stroke, or Severe Cognitive Decline?]
|
+-- Are you willing to perform large intramuscular (IM) injections?
|
+-- (No) -> Do not use Cerebrolysin. Use Semax or Dihexa instead.
|
+-- (Yes) -> Do you have severe kidney impairment?
|
+-- (Yes) -> Do not use Cerebrolysin.
|
+-- (No) -> Inject 5mL IM daily for 5 days on, 2 days off.
Run the cycle for 4 weeks.
Ensure adequate sleep and DHA intake.Schema.org Data.
{
"@context": "https://schema.org",
"@type": "MedicalEntity",
"name": "Cerebrolysin",
"alternateName": ["Porcine Brain-Derived Peptides"],
"description": "A multi-modal neurotrophic drug consisting of purified porcine brain peptides. Clinically approved in Europe and Asia for the treatment of acute ischemic stroke, traumatic brain injury, and Alzheimer's disease. Administered via IM or IV injection.",
"legalStatus": {
"@type": "DrugLegalStatus",
"description": "Approved in Europe/Asia. Unapproved in the US. Banned by WADA."
}
}What we cited.
- Fiani B, et al. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurol Sci. 2021;42(4):1345-1353. doi:10.1007/s10072-021-05089-2
- Brainin M, et al. Cerebrolysin: a multi-target drug for recovery after stroke. Expert Rev Neurother. 2018;18(8):681-687. doi:10.1080/14737175.2018.1500459
- Gavrilova SI, et al. Cerebrolysin in the therapy of mild cognitive impairment and dementia. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(8):116-123. doi:10.17116/jnevro2021121081116
- Gharagozli K, et al. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. J Med Life. 2017;10(3):153-160.
- Gauthier S, et al. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Dement Geriatr Cogn Disord. 2015;39(5-6):332-347. doi:10.1159/000375294
- Zhang D, et al. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017;2017:4191670. doi:10.1155/2017/4191670
- Muresanu DF, et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016;47(1):151-159. doi:10.1161/STROKEAHA.115.009416
- Strilciuc S, et al. Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals (Basel). 2021;14(12):1297. doi:10.3390/ph14121297
- Vester JC, et al. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN and CAPTAIN-II trials. Neurol Sci. 2021;42(10):4201-4211. doi:10.1007/s10072-021-05133-1